BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36706271)

  • 1. Successful Retransplantation With Killer Cell Immunoglobulin-like Receptor Ligand-mismatched Cord Blood in Infant Acute Lymphoblastic Leukemia That Relapsed After Transplantation.
    Mizuki K; Honda Y; Asai H; Higuchi N; Morita H; Yabe H; Kusuhara K
    J Pediatr Hematol Oncol; 2023 May; 45(4):e547-e550. PubMed ID: 36706271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Killer Cell Immunoglobulin-Like Receptor-Ligand Matching and Outcomes after Unrelated Cord Blood Transplantation in Acute Myeloid Leukemia.
    Rocha V; Ruggeri A; Spellman S; Wang T; Sobecks R; Locatelli F; Askar M; Michel G; Arcese W; Iori AP; Purtill D; Danby R; Sanz GF; Gluckman E; Eapen M;
    Biol Blood Marrow Transplant; 2016 Jul; 22(7):1284-1289. PubMed ID: 27090957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azacitidine successfully maintained the second remission in an infant with KMT2A-rearranged acute lymphoblastic leukemia who relapsed after unrelated cord blood transplantation.
    Chijimatsu I; Imanaka Y; Tomizawa D; Eguchi M; Nishimura S; Karakawa S; Miki M; Hamamoto K; Fujita N
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28675638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of KIR-ligand mismatch on pediatric T-cell acute lymphoblastic leukemia in unrelated cord blood transplantation.
    Kawahara Y; Ishimaru S; Tanaka J; Kako S; Hirayama M; Kanaya M; Ishida H; Sato M; Kobayashi R; Kato M; Goi K; Saito S; Koga Y; Hashii Y; Kato K; Sato A; Atsuta Y; Sakaguchi H
    Transplant Cell Ther; 2022 Sep; 28(9):598.e1-598.e8. PubMed ID: 35660064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide.
    Shimoni A; Labopin M; Lorentino F; Van Lint MT; Koc Y; Gülbas Z; Tischer J; Bruno B; Blaise D; Pioltelli P; Afanasyev B; Ciceri F; Mohty M; Nagler A
    Leukemia; 2019 Jan; 33(1):230-239. PubMed ID: 29907809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia.
    Willemze R; Rodrigues CA; Labopin M; Sanz G; Michel G; Socié G; Rio B; Sirvent A; Renaud M; Madero L; Mohty M; Ferra C; Garnier F; Loiseau P; Garcia J; Lecchi L; Kögler G; Beguin Y; Navarrete C; Devos T; Ionescu I; Boudjedir K; Herr AL; Gluckman E; Rocha V;
    Leukemia; 2009 Mar; 23(3):492-500. PubMed ID: 19151783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells enhance the impact of KIR receptor-ligand mismatching on acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia but not in those with acute lymphocytic leukemia.
    Zhang Y; Zheng H; Ren J; Luo X; Zheng Z; Zheng J; Zheng X; Chen Y; Chen Z; Hu J; Yang T
    Hematol Oncol; 2021 Aug; 39(3):380-389. PubMed ID: 33848027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD.
    Bishara A; De Santis D; Witt CC; Brautbar C; Christiansen FT; Or R; Nagler A; Slavin S
    Tissue Antigens; 2004 Mar; 63(3):204-11. PubMed ID: 14989709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six Years of Disease-free Survival After a Second Cord Blood Transplantation for Recurrent Acute Lymphocytic Leukemia in a Child With Down Syndrome.
    Aoshima M; Yagasaki H; Shimozawa K; Kanezawa K; Ueno M; Morioka I
    J Pediatr Hematol Oncol; 2024 Jan; 46(1):e100-e102. PubMed ID: 38063382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of missing KIR ligands, activating KIR genotype and haplotype on the outcome of T-cell-replete hematopoietic stem cell transplantation from HLA-identical siblings in Thai patients.
    Khanuntong S; Kuptawintu P; Upaisilpsathaporn K; Poolchareon A; Bunworasate U; Hirankarn N
    HLA; 2016 Jun; 87(6):422-31. PubMed ID: 27273744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced leukemia relapse through cytomegalovirus reactivation in killer cell immunoglobulin-like receptor-ligand-mismatched cord blood transplantation.
    Yokoyama H; Kanda J; Kawahara Y; Uchida N; Tanaka M; Takahashi S; Onizuka M; Noguchi Y; Ozawa Y; Katsuoka Y; Ota S; Ohta T; Kimura T; Kanda Y; Ichinohe T; Atsuta Y; Nakasone H; Morishima S
    Bone Marrow Transplant; 2021 Jun; 56(6):1352-1363. PubMed ID: 33420393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic Stem Cell Transplantation from HLA-Mismatched Donors for Pediatric Patients with Acute Lymphoblastic Leukemia Treated According to the 2003 BFM and 2007 International BFM Studies: Impact of Disease Risk on Outcomes.
    Dalle JH; Balduzzi A; Bader P; Lankester A; Yaniv I; Wachowiak J; Pieczonka A; Bierings M; Yesilipek A; Sedlaçek P; Ifversen M; Sufliarska S; Toporski J; Glogova E; Poetschger U; Peters C
    Biol Blood Marrow Transplant; 2018 Sep; 24(9):1848-1855. PubMed ID: 29772352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural Killer Cell Alloreactivity Predicted By Killer Cell Immunoglobulin-Like Receptor Ligand Mismatch Does Not Impact Engraftment in Umbilical Cord Blood and Haploidentical Stem Cell Transplantation.
    Otegbeye F; Vina MAF; Wang T; Bolon YT; Lazaryan A; Beitinjaneh A; Bhatt VR; Castillo P; Marsh SGE; Hildebrandt GC; Assal A; Brown VI; Hsu J; Spellman S; de Lima M; Lee SJ
    Transplant Cell Ther; 2022 Aug; 28(8):483.e1-483.e7. PubMed ID: 35643351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia.
    Cooley S; Weisdorf DJ; Guethlein LA; Klein JP; Wang T; Le CT; Marsh SG; Geraghty D; Spellman S; Haagenson MD; Ladner M; Trachtenberg E; Parham P; Miller JS
    Blood; 2010 Oct; 116(14):2411-9. PubMed ID: 20581313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cord blood transplantation from HLA-mismatched unrelated donors as a treatment for children with haematological malignancies.
    Ohnuma K; Isoyama K; Ikuta K; Toyoda Y; Nakamura J; Nakajima F; Tsuchida M; Ohira M; Suminoe A; Hara T; Nishihira H
    Br J Haematol; 2001 Mar; 112(4):981-7. PubMed ID: 11298596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved outcomes of single-unit cord blood transplantation for acute myeloid leukemia by killer immunoglobulin-like receptor 2DL1-ligand mismatch.
    Yokoyama H; Kanaya M; Iemura T; Hirayama M; Yamasaki S; Kondo T; Uchida N; Takahashi S; Tanaka M; Onizuka M; Ozawa Y; Kozai Y; Eto T; Sugio Y; Hamamura A; Kawakita T; Aotsuka N; Takada S; Wake A; Kimura T; Ichinohe T; Atsuta Y; Yanada M; Morishima S
    Bone Marrow Transplant; 2022 Jul; 57(7):1171-1179. PubMed ID: 35538140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two Occurrences of Leukemia Relapse Due to Mismatched HLA Loss After Haploidentical Stem Cell Transplantation From Different Family Donors With KIR Ligand Mismatch.
    Sano H; Mochizuki K; Kobayashi S; Ono S; Ikeda K; Ohto H; Kikuta A
    J Pediatr Hematol Oncol; 2020 Mar; 42(2):e104-e106. PubMed ID: 30807398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of myeloablative conditioning and unrelated donor hematopoietic cell transplantation for childhood acute lymphoblastic leukemia in third remission.
    Nemecek ER; Ellis K; He W; Bunin NJ; Bajwa RS; Cheerva A; Cairo MS; Dvorak C; Duval M; Davies S; Eapen M; Gross TG; Hussein AA; MacMillan ML; Mehta PA; Pulsipher MA; Seber A; Woolfrey AE; Frangoul HA; Carpenter PA
    Biol Blood Marrow Transplant; 2011 Dec; 17(12):1833-40. PubMed ID: 21683798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expansion of NKG2A-LIR1- natural killer cells in HLA-matched, killer cell immunoglobulin-like receptors/HLA-ligand mismatched patients following hematopoietic cell transplantation.
    Rathmann S; Glatzel S; Schönberg K; Uhrberg M; Follo M; Schulz-Huotari C; Kaymer M; Veelken H; Finke J; Fisch P
    Biol Blood Marrow Transplant; 2010 Apr; 16(4):469-81. PubMed ID: 20044012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.